What is the primary focus of Phase II trials?

Prepare for the Drug Discovery and Healthcare Systems Test. Access flashcards and multiple-choice questions with hints and explanations. Ace your exam with our comprehensive resources!

Multiple Choice

What is the primary focus of Phase II trials?

Phase II trials aim to establish preliminary evidence of efficacy in the target patient population and to define the dose-response relationship. They build on phase I safety data and test multiple doses in patients with the disease to identify an effective dose range while continuing to monitor safety. These studies are typically intermediate in size and may be randomized or single-arm, focusing on clinical outcomes or relevant biomarkers that suggest therapeutic benefit. This phase helps decide whether to move on to large-scale confirmatory testing in phase III and to select the dose(s) for those pivotal trials. In contrast, large-scale efficacy confirmation occurs in phase III, post-marketing surveillance happens in phase IV, and manufacturing process development is not a trial phase.

Phase II trials aim to establish preliminary evidence of efficacy in the target patient population and to define the dose-response relationship. They build on phase I safety data and test multiple doses in patients with the disease to identify an effective dose range while continuing to monitor safety. These studies are typically intermediate in size and may be randomized or single-arm, focusing on clinical outcomes or relevant biomarkers that suggest therapeutic benefit. This phase helps decide whether to move on to large-scale confirmatory testing in phase III and to select the dose(s) for those pivotal trials. In contrast, large-scale efficacy confirmation occurs in phase III, post-marketing surveillance happens in phase IV, and manufacturing process development is not a trial phase.

More practice questions